Novo Nordisk
NVO
46,69 €
Prix de l'action
-21.83%
Changement (1 jour)
-60.56%
Changement (1 an)
Catégories
Novo Nordisk (NVO) - Dette totale
Dette totale au bilan au Mars 2025 : 14.90 Milliards d'euros
Selon les derniers rapports financiers de Novo Nordisk, la dette totale de l'entreprise est de 14.90 Milliards d'euros. La dette totale d'une entreprise est la somme de toutes les dettes courantes et non courantes.
Novo Nordisk - Dette totale au bilan (de 1996 à 2025)
Dette totale par année
| Année | Dette totale | Changement |
|---|---|---|
| 2024-12-31 | €13.78 Md | 280.93% |
| 2023-12-31 | €3.61 Md | 4.52% |
| 2022-12-31 | €3.46 Md | -3.36% |
| 2021-12-31 | €3.58 Md | 157.38% |
| 2020-12-31 | €1.39 Md | 131.95% |
| 2019-12-31 | €0.60 Md | 769.93% |
| 2018-12-31 | €68.97 M | -69.7% |
| 2017-12-31 | €0.22 Md | 638.37% |
| 2016-12-31 | €30.82 M | -78.57% |
| 2015-12-31 | €0.14 Md | 48.73% |
| 2014-12-31 | €96.69 M | 235.46% |
| 2013-12-31 | €28.82 M | -57% |
| 2012-12-31 | €67.02 M | -41.43% |
| 2011-12-31 | €0.11 Md | -61.65% |
| 2010-12-31 | €0.29 Md | 59.89% |
| 2009-12-31 | €0.18 Md | -40.15% |
| 2008-12-31 | €0.31 Md | 70.39% |
| 2007-12-31 | €0.18 Md | -10.07% |
| 2006-12-31 | €0.20 Md | -43.44% |
| 2005-12-31 | €0.35 Md | 57.09% |
| 2004-12-31 | €0.22 Md | -1.59% |
| 2003-12-31 | €0.23 Md | 11.98% |
| 2002-12-31 | €0.20 Md | -30.55% |
| 2001-12-31 | €0.29 Md | 2.01% |
| 2000-12-31 | €0.29 Md | -5.92% |
| 1999-12-31 | €0.31 Md | -14.33% |
| 1998-12-31 | €0.36 Md | -11.13% |
| 1997-12-31 | €0.40 Md | 35.06% |
| 1996-12-31 | €0.30 Md |
Dette totale pour des entreprises similaires ou concurrentes
| Entreprise | Dette totale/th> | Dette totale différencediff. | Pays |
|---|---|---|---|
 Pfizer PFE | €53.05 Md | 256.00% | 🇺🇸 USA |
 Eli Lilly LLY | €33.33 Md | 123.72% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | €44.35 Md | 197.62% | 🇺🇸 USA |
 Sanofi SNY | €19.71 Md | 32.26% | 🇫🇷 France |